Literature DB >> 25595309

Segmental duodenal resection: indications, surgical techniques and postoperative outcomes.

D Dorcaratto1, H M Heneghan, B Fiore, F Awan, D Maguire, J Geoghegan, K Conlon, E Hoti.   

Abstract

INTRODUCTION: Segmental duodenal resections (DR) have been increasingly performed for the treatment of primary duodenal tumours. The aim of the study is to review the indications for, clinical and operative details, and outcomes of patients undergoing elective DR.
MATERIAL AND METHODS: We retrospectively reviewed all patients who underwent elective segmental DR for the treatment of primary duodenal tumours, at a single institution between January 2007 and December 2013. Demographic data, clinical presentation, preoperative investigations, operative details, postoperative complications/mortality and histopathological results were recorded.
RESULTS: In the study period, 11 duodenal resections were performed (7 male, median age 61 years). Thirty-six percent of the patients presented with anaemia. Surgical resection included two or more segments in seven patients. The most frequently resected part of the duodenum was segment 3 (n = 7). Median operative time was 191 min and blood loss was 675 ml. End-to-end and end-to-side anastomoses were performed in equal numbers. The pathology of resected specimens included adenocarcinoma (n = 4), gastrointestinal stromal tumour (GIST) (n = 1), adenoma (n = 5) and lymphoma (n = 1). Median hospital stay was 14 days. Overall, 30-day morbidity rate was 82% (78% Clavien 2 or less).
CONCLUSIONS: Segmental duodenal resection is a safe and effective surgical technique for the resection of primary duodenal tumours.

Entities:  

Mesh:

Year:  2015        PMID: 25595309     DOI: 10.1007/s11605-015-2744-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  21 in total

Review 1.  The role of endoscopy in ampullary and duodenal adenomas.

Authors:  Douglas G Adler; Waqar Qureshi; Raquel Davila; S Ian Gan; David Lichtenstein; Elizabeth Rajan; Bo Shen; Marc J Zuckerman; Robert D Fanelli; Trina Van Guilder; Todd H Baron
Journal:  Gastrointest Endosc       Date:  2006-12       Impact factor: 9.427

Review 2.  Surgical treatment of peptic ulcer disease.

Authors:  A K Sachdeva; H A Zaren; B Sigel
Journal:  Med Clin North Am       Date:  1991-07       Impact factor: 5.456

3.  Pancreas-sparing duodenectomy for gastrointestinal stromal tumor.

Authors:  Suguru Yamashita; Yoshihiro Sakamoto; Akio Saiura; Junji Yamamoto; Tomoo Kosuge; Taku Aoki; Yasuhiko Sugawara; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Am J Surg       Date:  2013-10-10       Impact factor: 2.565

4.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-Liang Han; Jun Cheng; Hong-Zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2010-12

5.  Adenocarcinoma of the third duodenal portion: Case report and review of literature.

Authors:  Federico Sista; Giuseppe De Santis; Antonio Giuliani; Emanuela Marina Cecilia; Federica Piccione; Laura Lancione; Sergio Leardi; Gianfranco Amicucci
Journal:  World J Gastrointest Surg       Date:  2012-01-27

6.  What prognostic factors are important in duodenal adenocarcinoma?

Authors:  F G Bakaeen; M M Murr; M G Sarr; G B Thompson; M B Farnell; D M Nagorney; D R Farley; J A van Heerden; L M Wiersema; C D Schleck; J H Donohue
Journal:  Arch Surg       Date:  2000-06

7.  Duodenal gastrointestinal stromal tumors (GISTs): arguments for conservative surgery.

Authors:  Stéphane Bourgouin; Emmanuel Hornez; Jérôme Guiramand; Louise Barbier; Jean-Robert Delpero; Yves-Patrice Le Treut; Vincent Moutardier
Journal:  J Gastrointest Surg       Date:  2012-11-15       Impact factor: 3.452

8.  Gastrointestinal stromal tumour of the duodenum: single institution experience.

Authors:  Ashwin S Kamath; Michael G Sarr; David M Nagorney; Florencia G Que; Michael B Farnell; Michael L Kendrick; Kaye M Reid Lombardo; John H Donohue
Journal:  HPB (Oxford)       Date:  2012-08-17       Impact factor: 3.647

9.  Limited resection for duodenal gastrointestinal stromal tumors: Surgical management and clinical outcome.

Authors:  Jens Hoeppner; Birte Kulemann; Goran Marjanovic; Peter Bronsert; Ulrich Theodor Hopt
Journal:  World J Gastrointest Surg       Date:  2013-02-27

10.  Pancreaticoduodenectomy versus local resection in the treatment of gastrointestinal stromal tumors of the duodenum.

Authors:  Bo Zhou; Min Zhang; Jian Wu; Sheng Yan; Jie Zhou; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2013-08-14       Impact factor: 2.754

View more
  5 in total

1.  A Case of Duodenal Resection and Duodenojejunostomy for Multiple Small Bowel Infarction in Patient With Inherited Thrombophilia and Vitamin K Antagonist Induced Critical Hypocoagulation.

Authors:  Badri Kobalava; Anzor Kvashilava; Giorgi Giorgobiani; Irina G Datikashvili-David; Nana Turava
Journal:  Cureus       Date:  2021-02-04

2.  Surgery for Duodenal Gastrointestinal Stromal Tumors: A Single-Center Experience.

Authors:  Ping Chen; Tianqiang Song; Xin Wang; Hongyuan Zhou; Ti Zhang; Qiang Wu; Dalu Kong; Yunlong Cui; Huikai Li; Qiang Li
Journal:  Dig Dis Sci       Date:  2017-09-15       Impact factor: 3.199

3.  Side-to-side duodenojejunostomy after resection of third and fourth duodenal portions with pancreatic preservation.

Authors:  Gerardo Blanco-Fernández; Adela Rojas-Holguín; Noelia De-Armas-Conde; Isabel Gallarín-Salamanca; Diego López-Guerra; Isabel Jaén-Torrejimeno
Journal:  Updates Surg       Date:  2020-06-05

4.  Pancreas-preserving limited duodenal resection: Minimizing morbidity without compromising oncological adequacy.

Authors:  Ajay Sharma; Anand Nagar; Peeyush Varshney; Maunil Tomar; Shashwat Sarin; Rajendra Prasad Choubey; V K Kapoor
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-05-31

5.  Limited distal duodenal resection: Surgical approach and outcomes. A case series.

Authors:  Ankush Golhar; Vivek Mangla; Siddharth Mehrotra; Shailendra Lalwani; Naimish Mehta; Samiran Nundy
Journal:  Ann Med Surg (Lond)       Date:  2018-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.